BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 8005670)

  • 1. Affinity of the C9 molecule for the C5b-8 complex compared with that for the complex containing C9 molecules.
    MacKay SL; Dankert JR
    Infect Immun; 1994 Jul; 62(7):2800-5. PubMed ID: 8005670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formation of transmural complement pores in serum-sensitive Escherichia coli.
    Bhakdi S; Kuller G; Muhly M; Fromm S; Seibert G; Parrisius J
    Infect Immun; 1987 Jan; 55(1):206-10. PubMed ID: 3539803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C5b-9 assembly: average binding of one C9 molecule to C5b-8 without poly-C9 formation generates a stable transmembrane pore.
    Bhakdi S; Tranum-Jensen J
    J Immunol; 1986 Apr; 136(8):2999-3005. PubMed ID: 3958488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular organization of C9 within the membrane attack complex of complement. Induction of circular C9 polymerization by the C5b-8 assembly.
    Podack ER; Tschoop J; Müller-Eberhard HJ
    J Exp Med; 1982 Jul; 156(1):268-82. PubMed ID: 6177822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutathione-catalyzed disulfide-linking of C9 in the membrane attack complex of complement.
    Yamamoto K; Kawashima T; Migita S
    J Biol Chem; 1982 Aug; 257(15):8573-6. PubMed ID: 7096325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterial killing and inhibition of inner membrane activity by C5b-9 complexes as a function of the sequential addition of C9 to C5b-8 sites.
    MacKay SL; Dankert JR
    J Immunol; 1990 Nov; 145(10):3367-71. PubMed ID: 2230122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrastructure of the membrane attack complex of complement. Heterogeneity of the complex caused by different degree of C9 polymerization.
    Tschopp J
    J Biol Chem; 1984 Jun; 259(12):7857-63. PubMed ID: 6736027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement pores in erythrocyte membranes. Analysis of C8/C9 binding required for functional membrane damage.
    Sims PJ
    Biochim Biophys Acta; 1983 Aug; 732(3):541-52. PubMed ID: 6871214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transmembrane channel-formation by five complement proteins.
    Müller-Eberhard HJ
    Biochem Soc Symp; 1985; 50():235-46. PubMed ID: 2428370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.
    Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
    J Immunol; 1983 Nov; 131(5):2570-5. PubMed ID: 6355297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of the ratio of the eighth and ninth components of human complement on complement-lysed membranes.
    Stewart JL; Monahan JB; Brickner A; Sodetz JM
    Biochemistry; 1984 Aug; 23(18):4016-22. PubMed ID: 6487588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of homologous complement by CD59 is mediated by a species-selective recognition conferred through binding to C8 within C5b-8 or C9 within C5b-9.
    Rollins SA; Zhao J; Ninomiya H; Sims PJ
    J Immunol; 1991 Apr; 146(7):2345-51. PubMed ID: 1706395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9.
    Rollins SA; Sims PJ
    J Immunol; 1990 May; 144(9):3478-83. PubMed ID: 1691760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitronectin-mediated inhibition of complement: evidence for different binding sites for C5b-7 and C9.
    Milis L; Morris CA; Sheehan MC; Charlesworth JA; Pussell BA
    Clin Exp Immunol; 1993 Apr; 92(1):114-9. PubMed ID: 7682159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multimeric C9 within C5b-9 is required for inner membrane damage to Escherichia coli J5 during complement killing.
    Bloch EF; Schmetz MA; Foulds J; Hammer CH; Frank MM; Joiner KA
    J Immunol; 1987 Feb; 138(3):842-8. PubMed ID: 3100618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The killer molecule of complement.
    Müller-Eberhard HJ
    J Invest Dermatol; 1985 Jul; 85(1 Suppl):47s-52s. PubMed ID: 3891882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimeric C9 within C5b-9 deposits in unique locations in the cell wall of Salmonella typhimurium.
    Joiner KA; Tartanian AB; Hammer CH; Schweinle JE
    J Immunol; 1989 Jun; 142(12):4450-7. PubMed ID: 2656866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluid-phase assembly of the membrane attack complex of complement.
    Silversmith RE; Nelsestuen GL
    Biochemistry; 1986 Feb; 25(4):841-51. PubMed ID: 3964648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD59 blocks not only the insertion of C9 into MAC but inhibits ion channel formation by homologous C5b-8 as well as C5b-9.
    Farkas I; Baranyi L; Ishikawa Y; Okada N; Bohata C; Budai D; Fukuda A; Imai M; Okada H
    J Physiol; 2002 Mar; 539(Pt 2):537-45. PubMed ID: 11882685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent inhibition of terminal complement assembly by clusterin: characterization of its impact on C9 polymerization.
    McDonald JF; Nelsestuen GL
    Biochemistry; 1997 Jun; 36(24):7464-73. PubMed ID: 9200695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.